X0306 4 2021-10-04 0001868726 OLAPLEX HOLDINGS, INC. OLPX 0001034196 ADVENT INTERNATIONAL CORP/MA PRUDENTIAL TOWER 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true true 0001774610 Advent International GPE IX Limited Partnership PRUDENTIAL TOWER 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true true 0001774614 Advent International GPE IX-B Limited Partnership PRUDENTIAL TOWER 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true true 0001774608 Advent International GPE IX-C Limited Partnership PRUDENTIAL TOWER 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true true 0001774607 Advent International GPE IX-F Limited Partnership PRUDENTIAL TOWER 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true true 0001774606 Advent International GPE IX-G Limited Partnership PRUDENTIAL TOWER 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true true 0001774605 Advent International GPE IX-H Limited Partnership PRUDENTIAL TOWER 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true true 0001774604 Advent International GPE IX-I Limited Partnership PRUDENTIAL TOWER 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true true 0001882492 GPE IX GP Limited Partnership PRUDENTIAL TOWER 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true true Common Stock 2021-10-04 4 S 0 68711029 19.8975 D 509775426 I See Notes See Exhibit 99.1 for text of footnote (1). See Exhibit 99.1 for text of footnote (2). See Exhibit 99.1 for text of footnote (3). See Exhibit 99.1 for text of footnote (4). See Exhibit 99.1 for text of footnote (5). David Mussafer, the Chairman and Managing Partner of Advent, Tricia Glynn, a Managing Director of Advent and Michael White, a Principal of Advent (together, the "Advent Directors"), each serve on the board of directors of the Issuer, and have been deputized to represent the Reporting Persons on the board of directors. By virtue of the Advent Directors' representation, for purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons may be deemed directors by deputization of the Issuer. The Advent Directors have filed separate Section 16 reports disclosing securities of the Issuer that they may be deemed to beneficially own for Section 16 purposes. Exhibit 99.1 (Footnotes to Form 4) and Exhibit 99.2 (Signatures and Joint Filer Information) are incorporated by reference. Form 1 of 3: This Form 4 is the first of three Forms 4 being filed relating to the same event. The Form 4 has been split into multiple filings because there are more than 10 Reporting Persons total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. Each Form 4 will be filed by Designated Filer Advent International Corporation. ADVENT INTERNATIONAL CORPORATION, By: /s/ Neil Crawford, Name: Neil Crawford, Title: Director, Fund Administration 2021-10-06